# Innovative Intermittent Preventive Treatment Approaches to Reduce Malaria Burden in School-age Children in Burkina Faso

> **NCT05946642** · PHASE3 · UNKNOWN · sponsor: **Malaria Consortium** · enrollment: 13000 (estimated)

## Conditions studied

- Malaria

## Interventions

- **DRUG:** Sulphadoxine-Pyrimethamine/Amodiaquine
- **DRUG:** Dihydroartemisinin/Piperaquine (DP) plus Ivermectin (IVM)

## Key facts

- **NCT ID:** NCT05946642
- **Lead sponsor:** Malaria Consortium
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-07-15
- **Primary completion:** 2024-05-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 13000 (ESTIMATED)
- **Last updated:** 2023-11-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05946642

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05946642, "Innovative Intermittent Preventive Treatment Approaches to Reduce Malaria Burden in School-age Children in Burkina Faso". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05946642. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*